Menu
Kerecis SurgiClose Micro is intact decellularized fish skin especially developed for trauma wounds and surgical wounds in the operating room. The fish skin sheets contain; fat, protein, elastin, glycans and other natural skin elements. Kerecis SurgiClose Micro has been fragmented into smaller pieces to mold and insert into deep wound spaces and irregular geometries.
The product is a FDA 510(k) medical device indicated for managing wounds not subject to the May 31, 2021, FDA 351 regulation.
Kerecis SurgiClose Micro:
Disclaimer:
Kerecis SurgiClose Micro is not available in all countries and may be known under different trade names. Products, product names, indications and claims vary between jurisdictions.
Not Healthcare Advice
This Site is not intended to provide diagnosis, treatment or medical advice. Products, services, information and other content provided on this Site, including information that may be provided on this Site directly or by linking to third-party websites, are provided for informational purposes only. Information on this Site should not be considered as a substitute for advice from a healthcare professional. Please consult with a physician or other healthcare professional regarding any medical or health related diagnosis or treatment options.
Products are not available in all countries and may be known by different names than used on this web-page. Products, product names, indications and claims vary between countries. Always make sure to check with your local health care professional and read the actual printed package information prior to use. Information on this website might not be current and might not be an accurate reflection of current product labeling.
Surgeon Disclaimer
A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Kerecis does not dispense medical advice and recommends that surgeons be trained in the use of any particular product before using it in surgery.
The information presented is intended to demonstrate the Kerecis product offerings. A surgeon must always refer to the package insert, product label and/or instructions for use before using any Kerecis product. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your Kerecis representative if you have questions about the availability of Kerecis products in your area.
Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding cellular therapy and infection control markets.
